(Q40551294)

21 September 2017

title

Therapy with statins in patients with refractory rheumatic diseases: a preliminary study (English)

1 reference

21 September 2017

1 reference

C Abud-Mendoza

1

1 reference

21 September 2017

H de la Fuente

2

1 reference

21 September 2017

E Cuevas-Orta

3

1 reference

21 September 2017

L Baranda

4

1 reference

21 September 2017

J Cruz-Rizo

5

1 reference

21 September 2017

R González-Amaro

6

1 reference

21 September 2017

publication date

1 January 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

12

1 reference

21 September 2017

issue

8

1 reference

21 September 2017

page(s)

607-611

1 reference

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Lipid-lowering drugs in lupus: an unexplored therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

Pathobiochemistry of nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU429OA

10.1191/0961203303LU429OA

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference